PlainRecalls
FDA Drug Moderate Class II Terminated

LL-37 2 mg/mL (5 mL) Injection, 5 mL vials, Rx only, Farmakeio 1736 N Greenville Ave Richardson, TX 75081 USA

Reported: April 27, 2022 Initiated: April 5, 2022 #D-0778-2022

Product Description

LL-37 2 mg/mL (5 mL) Injection, 5 mL vials, Rx only, Farmakeio 1736 N Greenville Ave Richardson, TX 75081 USA

Reason for Recall

Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.

Details

Units Affected
25 vials
Distribution
Nationwide within United States
Location
Richardson, TX

Frequently Asked Questions

What product was recalled?
LL-37 2 mg/mL (5 mL) Injection, 5 mL vials, Rx only, Farmakeio 1736 N Greenville Ave Richardson, TX 75081 USA. Recalled by North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding. Units affected: 25 vials.
Why was this product recalled?
Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.
Which agency issued this recall?
This recall was issued by the FDA Drug on April 27, 2022. Severity: Moderate. Recall number: D-0778-2022.